The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis

BACKGROUND: Retinopathy of prematurity (ROP) is typically treated with laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF). To the best of our knowledge, most systematic reviews have focused on comparing anti-VEGF against laser treatment while comparisons b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Hao, Qingfei, Zhang, Jing, Du, Yanna, Chen, Haoming, Cheng, Xiuyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561404/
https://www.ncbi.nlm.nih.gov/pubmed/37814332
http://dx.doi.org/10.1186/s13052-023-01543-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561404/
https://www.ncbi.nlm.nih.gov/pubmed/37814332
http://dx.doi.org/10.1186/s13052-023-01543-3

Ejemplares similares